Racial Disparities and COVID-19

COVID-19 is inequitably impacting racial and ethnic sub-populations in the United States, with African Americans and other underrepresented groups contracting and dying of COVID-19 at markedly disproportionate rates.

As part of PHR’s webinar series, “Science-driven solutions for Combating COVID-19,” PHR board vice-chair Deborah Ascheim, MD, president of D2A Ltd., moderated a conversation featuring:

Distinguished panelists:

  • Dererk Griffith, PhD is founder and director of the Center for Research on Men’s Health and professor of Medicine, Health and Society at Vanderbilt University. His research focuses on developing and implementing behavioral and policy strategies to achieve equity in health and well-being by race, ethnicity, and gender. He has been the principal investigator of research grants from the American Cancer Society and the Robert Wood Johnson Foundation, among other foundations, and several institutes within the National Institutes of Health
  • Carol R. Horowitz, MD, MPH is the founding dean for gender equity in science and medicine at the Icahn School of Medicine at Mount Sinai. She is professor in the departments of population health science and policy, and medicine, and co-directs Mount Sinai’s Center for Health Equity and Community Engaged Research. Her research focuses on using community- and stakeholder-engaged approaches to understand and eliminate health disparities related to common chronic diseases. As principal and investigator for federally funded studies, her special interests are in chronic disease prevention and control, and the intersection of race, ancestry, genomics, and health. She has been principal investigator and co-investigator on numerous NIH, CDC, and Patient-Centered Outcomes Research Institute grants related to chronic disease prevention and control.
  • Monica Peek, MD, MPH is an associate professor of medicine at the University of Chicago Medicine, where she serves as director of research and associate director for the MacLean Center for Clinical Medical Ethics, associate director for the Chicago Center for Diabetes Translation Research, and executive director for community health innovation. She is co-director of the national program office for Bridging the Gap: Reducing Disparities in Diabetes Care.

The conversation was moderated by Deborah D. Ascheim, MD, president of D2A Ltd., PHR Vice-Chair of the Board of Directors.

See all events on PHR’s COVID-19 Webinar Series.

Get Updates from PHR